Nano Dimension Provides Update on Proposed Business Combination with Infinite Epigenetics
Nano Dimension (NASDAQ:NNDM) has issued an update regarding its proposed business combination with Infinite Epigenetics. The company highlighted that the transaction is still under negotiation and emphasized Infinite's operational strengths, including a CLIA-certified lab and commercial revenue.
Tickers: $NNDM
Topics: business combination epigenetics healthcare technology